TCL Archive In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System July 19, 1996
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003